SAHA-treated neuroblastoma cells demonstrated dose-dependent decreases in the levels of Ku70 and c-FLIPL, with induction of caspase 8 activation and PARP cleavage indicative of induction of apoptosis (Fig. 5B and Supplemental Fig. 3A). The gene discussed is CFLAR; the disease is neuroblastoma.